Skip to main content

Advertisement

SpringerLink
Log in

Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure

  • DIAGNOSTIC NEURORADIOLOGY
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Gadolinium based MRI contrast agents are considered very safe due to their well known pharmacologic properties and elimination mechanisms. In this paper, we present a unique case in whom transient enhancement of CSF with contrast is seen. Severe renal failure is demonstrated to be responsible for this finding. The diagnostic criteria for everyday clinical setting and possible clinical implications are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Radiology, New England Medical Center Hospitals and Tufts University School of Medicine, NEMC #299, New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111, USA e-mail: serbay@lifespan.org Tel.: + 1-6 17-6 36 00 47 Fax: + 1-6 17-6 36 00 41, GB

    S. H. Erbay & R. A. Bhadelia

Authors
  1. S. H. Erbay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Bhadelia
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 6 September 2000/Accepted: 1 February 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erbay, S., Bhadelia, R. Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure. Neuroradiology 43, 1001–1004 (2001). https://doi.org/10.1007/s002340100606

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002340100606

Search

Navigation